LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
LB Pharmaceuticals granted an inducement award of 75,000 stock options to Christopher Zergebel, its new Senior Vice President of Clinical Operations. The options carry an exercise price of $32.95, equal to the closing price on the grant date, and vest over four years.
Key figures
- Option shares
- 75000
- Vesting years
- 4
- Exercise price
- $32.95
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.